Healthy potentially undervalued

Results

2442

Companies which are potentially undervalued and in an acceptable financial position.

2442 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	4005	ر.س105.10	-0.1%	-36.5%	ر.س4.7b	ر.س139.50	16.4	9.5%	2.9%	Healthcare
	GPP	zł45.90	4.3%	-26.4%	zł3.2b	zł59.32	13.4	8.4%	6.5%	Commercial Services
	FGR	€127.90	-2.6%	8.7%	€12.2b	€161.21	11.9	7.3%	3.8%	Capital Goods
	TESB	€20.30	2.1%	-22.2%	€1.2b	€25.50	0.4	74.6%	3.7%	Materials
	ADUS	US$105.17	8.6%	-6.0%	US$1.9b	US$132.69	19.3	11.1%	n/a	Healthcare
	ANF	US$92.42	3.4%	0.9%	US$4.1b	US$111.30	8.3	0.9%	0%	Retail
	TCW	CA$6.69	-0.7%	28.7%	CA$1.4b	CA$8.38	12.7	7.1%	3.3%	Energy
	SAM	US$183.62	1.9%	-8.7%	US$1.8b	US$230.39	1.0	38.4%	n/a	Food, Beverage & Tobacco
	CEVI	SEK 142.80	2.9%	-22.3%	SEK 3.4b	SEK 177.75	25.4	16.7%	1.9%	Healthcare
	DIS	€6.99	-12.4%	99.0%	€831.0m	€8.60	9.8	-2.2%	5.1%	Energy
	INF	€39.95	3.8%	1.1%	€273.3m	€51.55	16.9	13.4%	5.0%	Software
	HER	€3.73	1.3%	-5.9%	€5.5b	€4.52	11.9	3.3%	4.3%	Utilities
	EGLA	€0.94	4.0%	-56.8%	€153.7m	€1.23	0.2	100.8%	4.4%	Capital Goods
	CDA	€22.20	-0.4%	7.0%	€1.1b	€27.45	9.6	3.3%	5.0%	Consumer Services
	FNTN	€22.98	-4.8%	-16.7%	€2.7b	€27.76	10.4	5.7%	9.0%	Telecom
	ATMU	US$49.71	-8.2%	31.6%	US$4.1b	US$66.40	19.2	10.9%	0.4%	Capital Goods
	HITI	CA$3.23	3.5%	1.3%	CA$283.8m	CA$7.30	0.4	172.6%	n/a	Pharmaceuticals & Biotech
	SSRM	CA$43.42	7.6%	142.2%	CA$8.3b	CA$61.35	11.3	8.9%	0%	Materials
	CABKA	€2.02	1.0%	-0.5%	€49.9m	€3.28	0.3	105.5%	0%	Materials
	LKQ	US$26.55	-0.7%	-31.4%	US$6.7b	US$40.81	13.1	14.4%	4.5%	Retail
	GAMA	UK£8.58	2.3%	-24.5%	UK£772.0m	UK£13.99	11.9	3.5%	2.6%	Telecom
	OSB	UK£5.41	0.5%	1.7%	UK£1.8b	UK£6.78	6.7	6.0%	6.5%	Diversified Financials
	TRLV	US$9.78	14.8%	153.4%	US$1.8b	US$19.56	1.6	128.8%	n/a	Pharmaceuticals & Biotech
	FOUR	UK£37.80	2.8%	-0.5%	UK£1.1b	UK£49.23	12.5	-5.3%	4.8%	Media

Page 1 of 68